业务
货币单位:美元
2024/Q1
名称营收比例
Coronavirus disease 2019 (COVID-19)2,312.8万42.73%
Human immunodeficiency virus (HIV)1,338万24.72%
Molecular Sample Management Solutions1,082.2万19.99%
Hepatitis C virus (HCV)300万5.54%
Risk assessment testing208万3.84%
Molecular Services87.3万1.61%
Other product and service revenues49.6万0.92%
Non-product and services revenues35.3万0.65%
查看全部
地区
货币单位:美元
2023/FY
名称营收比例
美国3.62亿89.19%
其他地区3,570.1万8.80%
欧洲811.1万2.00%
